SGC-iMLLT is primarily utilized in the field of chemical biology and drug discovery, particularly in the study of protein-protein interactions and epigenetic regulation. It serves as a potent and selective inhibitor targeting specific protein domains, enabling researchers to dissect complex biological pathways and understand the role of certain proteins in disease mechanisms. This compound is often employed in experimental settings to investigate the modulation of chromatin-associated proteins, which play a critical role in gene expression and cellular function. Its application extends to the development of therapeutic strategies for diseases such as cancer, where dysregulation of epigenetic machinery is a key factor. Additionally, SGC-iMLLT is used as a tool compound in high-throughput screening assays to identify novel drug candidates and validate potential targets in preclinical research.